Prevalence of immature survival data for anti-cancer drugs presented to the National Institute for Health and Care Excellence between 2018-2022

Gibbons, C.L. and Latimer, N.R. orcid.org/0000-0001-5304-5585 (2024) Prevalence of immature survival data for anti-cancer drugs presented to the National Institute for Health and Care Excellence between 2018-2022. Value in Health. ISSN 1098-3015

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors. Except as otherwise noted, this author-accepted version of a journal article published in Value in Health is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

Keywords: NICE; decision-making; health technology assessment; immature survival data; oncology
Dates:
  • Published: 24 December 2024
  • Published (online): 24 December 2024
  • Accepted: 27 November 2024
  • Submitted: 16 February 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Funding Information:
Funder
Grant number
Yorkshire Cancer Research
S406NL
Depositing User: Symplectic Sheffield
Date Deposited: 10 Jan 2025 14:29
Last Modified: 10 Jan 2025 14:29
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.jval.2024.11.013
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics